Eugene Ruzagira

Government of Uganda - Uganda Virus Research Institute (UVRI)

SCHOLARLY PAPERS

3

DOWNLOADS

130

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals

Number of pages: 60 Posted: 19 Feb 2025
London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Imperial College London - Department of Infectious Disease, Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, MRC/UVRI & LSHTM Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease and London School of Hygiene & Tropical Medicine - Uganda Research Unit
Downloads 63 (761,262)

Abstract:

Loading...

Self-amplifying RNA (saRNA) vaccine, SARS-CoV-2 immunogenicity, COVID-19 Vaccination in Africa, Neutralising antibody responses, Spike-specific IgG antibodies, Vaccine safety and reactogenicity, Seronegative vs. seropositive immune response

2.

Acceptability and Applicability of Biometric Iris Scanning for the Identification and Follow Up of Highly Mobile Research Participants Living in Fishing Communities Along the Shores of Lake Victoria in Kenya, Tanzania, and Uganda

Number of pages: 24 Posted: 29 Nov 2022
Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Kenya Medical Research Institute (KEMRI), UVRI-IAVI HIV Vaccine Program, London School of Hygiene & Tropical Medicine - Uganda Research Unit, International AIDS Vaccine Initiative, New York, Kenya Medical Research Institute (KEMRI), National Institute for Medical Research (NIMR) - Mwanza Medical Research Centre, Government of Uganda - Uganda Virus Research Institute (UVRI), UVRI-IAVI HIV Vaccine Program, International AIDS Vaccine Initiative, Kenya Medical Research Institute (KEMRI), UVRI-IAVI HIV Vaccine Program, Government of Uganda - Uganda Virus Research Institute (UVRI), International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, Government of Uganda - Uganda Virus Research Institute (UVRI), Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine - Department of Global Health and Development and Mwanza Intervention Trials Unit
Downloads 35 (992,242)

Abstract:

Loading...

East Africa, fishing communities, Lake Victoria, acceptability, iris scanning, biometric identification

3.

A Comparison of F/TAF and F/TDF as HIV Pre-Exposure Prophylaxis in a Predominantly Cisgender Women Population in East and South Africa: A Randomised, Factorial, Non-Inferiority Trial

Number of pages: 31 Posted: 01 May 2025
University College London - MRC Clinical Trials Unit, Medical Research Council Clinical Trials Unit at UCL, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, Muhimbili University of Health and Allied Sciences, South African Medical Research Council, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, University College London - MRC Clinical Trials Unit, Assistance Publique-Hôpitaux de Paris - Hôpital Saint-Louis, Imperial College London, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, London School of Hygiene and Tropical Medicine - Uganda Research Unit, EuroVacc Foundation, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, IAVI, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Muhimbili University of Health and Allied Sciences, Medical Research Council Clinical Trials Unit at UCL, South African Medical Research Council, Medical Research Council Clinical Trials Unit at UCL, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, Mbeya Medical Research Center, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, Mbeya Medical Research Center, IAVI, Imperial College London, South African Medical Research Council, International AIDS Vaccine Initiative, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, Mbeya Medical Research Center, Medical Research Council Clinical Trials Unit at UCL, IAVI, South African Medical Research Council, Muhimbili University of Health and Allied Sciences, Muhimbili University of Health and Allied Sciences, Muhimbili University of Health and Allied Sciences, National Institute for Medical Research (NIMR), Eastern Virginia Medical School - CONRAD, London School of Hygiene & Tropical Medicine - Department of Global Health and Development, Imperial College London, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, Guy's and St Thomas' NHS Foundation Trust - Department of Infection, Government of Uganda - Uganda Virus Research Institute (UVRI), South African Medical Research Council, South African Medical Research Council and South African Medical Research Council
Downloads 32 (1,024,170)

Abstract:

Loading...

HIV, Pre-exposure prophylaxis, Prevention, Risk of HIV infection, F/TAF